Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1996;87:1014-1018
© 1996 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fletcher, H
Right arrow Articles by Simeon, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fletcher, H
Right arrow Articles by Simeon, D

Articles

A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy

H Fletcher, J Frederick, M Hardie, and D Simeon

OBJECTIVE: To assess the comparative efficacy of perivascular vasopressin and tourniquet in minimizing bleeding and its sequelae at myomectomy. METHODS: Between March 1994 and February 1995, 52 women with symptomatic uterine leiomyomas scheduled for myomectomy were entered into a randomized trial comparing vasopressin (26 patients) and tourniquet (26 patients) for hemostasis. Myomectomy was performed after either the perivascular injection of 20 U of vasopressin diluted to 20 mL with normal saline or with the use of a Foley catheter tourniquet around both uterine vessels. The efficacy of each method was measured by comparing differences in pre- and postoperative hemoglobin levels, intraoperative blood pressure, measured blood loss, need for blood transfusion, evidence of postoperative febrile morbidity, complications, and length of hospital stay. RESULTS: Vasopressin resulted in less blood loss (mean 287.3 mL [standard deviation (SD) 195] versus 512.7 mL [SD 400] for tourniquet [P = .036]). Six of 26 patients in the tourniquet group lost more than 1000 mL of blood, whereas all of the vasopressin subjects lost less than this amount (P = .023). However, there were no significant differences between the two groups in the fall in the hemoglobin level, number of blood transfusions given, intraoperative blood pressure, highest postoperative pulse and temperature, or other complications. CONCLUSION: Vasopressin prevents blood loss better than using the tourniquet during myomectomy.


This article has been cited by other articles:


Home page
 Canadian J. AnesthesiaHome page
A. Deschamps and S. Krishnamurthy
Absence of pulse and blood pressure following vasopressin injection for myomectomy
Can J Anesth, May 1, 2005; 52(5): 552 - 553.
[Full Text] [PDF]

Home page
 Obstet GynecolHome page
F. Zullo, S. Palomba, D. Corea, M. Pellicano, T. Russo, A. Falbo, E. Barletta, P. Saraco, P. Doldo, and E. Zupi
Bupivacaine Plus Epinephrine for Laparoscopic Myomectomy: A Randomized Placebo-Controlled Trial
Obstet. Gynecol., August 1, 2004; 104(2): 243 - 249.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
C. R. OKIN, R. S. GUIDO, L. A. MEYN, and S. RAMANATHAN
Vasopressin During Abdominal Hysterectomy: A Randomized Controlled Trial
Obstet. Gynecol., June 1, 2001; 97(6): 867 - 872.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Obstetricians and Gynecologists.